Skip to main content
. 2020 May 20;181(7):1489–1501.e15. doi: 10.1016/j.cell.2020.05.015

Figure 1.

Figure 1

SARS-CoV-2 IgM, IgA, and IgG Responses of Recovered COVID-19 Patients

(A–C) Plasma ELISA titers to SARS-CoV-2 spike RBD. (A) IgG. (B) IgM. (C) IgA. Neg, unexposed donors from 2015–2018 (n = 20); COVID, convalescing COVID-19 patients (n = 20). All data are shown as ELISA titers based on a standard. The dotted line indicates limit of detection. Geometric mean titers with geometric SDs are indicated.

(D–I) Immunophenotyping of mononuclear leukocytes. Frequency of (D) CD3+ total T cells, (E) CD4+ T cells (CD4+CD3+), (F) CD8+ T cells (CD8+CD3+), (G) CD19+ B cells (CD19+CD3), (H) CD3CD19 cells, and (I) CD14+CD16 monocytes (CD3CD19CD56) from the PBMCs of unexposed donors (Neg, n = 13) or convalescing COVID-19 patients (COVID, n = 14). Data were analyzed using the Mann-Whitney test with mean and standard deviation shown.

p < 0.05, ∗∗∗∗p < 0.0001. See also Figures S1 and S2.